ArticleCureus2026
An Atypical Presentation of Morel-Lavallée Syndrome Following Blunt Trauma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Morel-Lavallée syndrome (MLS) refers to a closed internal degloving injury resulting from tangential shearing forces, which cause separation of the skin and subcutaneous layers from the underlying deep fascia, with subsequent collection of hemolymphatic fluid and devitalized adipose tissue in the created potential space. Despite its rarity, MLS contributes substantially to soft-tissue shear injuries and is commonly underdiagnosed, with consequent delays in treatment and related complications. A 44-year-old female reported localized pain with a progressively enlarging swelling involving the inferomedial aspect of the right thigh subsequent to a road-traffic accident. Clinical examination revealed a large, well-defined, fluctuant, non-tender swelling with overlying bluish-black discoloration and no neurovascular compromise. Ultrasonography reported a well-circumscribed fluid collection located between the subcutaneous adipose tissue and the underlying fascia, with no associated bony injury on radiography. Given a high index of suspicion for MLS, early surgical intervention was undertaken within 72 hours of injury. Incision and drainage revealed clear separation of the subcutaneous tissue from the fascia, with evacuation of approximately 200 cc of hematoma. The postoperative course was uneventful, and secondary suturing was performed on day five, with no evidence of infection or residual collection during the inpatient stay. MLS commonly involves the peri-trochanteric region but may present at atypical sites such as the medial thigh. The lesion can mimic cellulitis, abscess, or hematoma, underscoring the importance of clinical suspicion. Previous literature indicates that ultrasonography is useful for the early detection of Morel-Lavallée lesions, whereas magnetic resonance imaging is preferred for the evaluation of established or chronic lesions. Evidence derived mainly from retrospective series and narrative reviews suggests that early percutaneous or surgical drainage has been associated with lower rates of recurrence and morbidity; however, outcomes may vary, and the quality of evidence remains limited. In patients with persistent or recurrent collections, definitive surgical management such as capsulectomy, minimally invasive approaches, or sclerotherapy, with doxycycline emerging as an effective sclerosant, has been described. This case report highlights the importance of maintaining a high index of suspicion for MLS in atypical clinical presentations and demonstrates that early recognition, followed by timely drainage and structured postoperative care, may help prevent progression to chronicity, recurrence, and secondary infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.